Key Words: Alcoholic liver disease; Alcoholic steatosis; Alcoholic hepatitis; Gut microbiota; Lipopolysaccharide; Steroid non-response Core tip: With better treatment options available for other liver diseases like viral hepatitis the proportion of alcoholic liver disease is on the rise. Alcoholic hepati...
The article discusses the development of improved and more effective treatments for chronic hepatitis C virus (HCV) infection in the U.S. Overview of the statistics of population infected with the virus worldwide, the symptoms felt by patients, and their risk factors is discussed. The development...
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis. Chronic hepatitis C virus is difficult to treat and affects approximately 3 million Americans. Protease inhibitors increase the effectiveness of standard t... L Shan,LE Cipriano,M Holodniy,... - 《An...
About 130-170 million people, is estimated to be infected with the hepatitis C virus(HCV). Chronic HCV infection is one of the leading causes of liverrelated death and in many countries it is the primaryreason for having a liver transplant. The main aim of antiviral treatment is to ...
Learn more about ravidasvir/sofosbuvir treatment, a new 12-week course of daily Hepatitis C treatment that was demonstrated in clinical trials to completely stamp out traces of HCV from 97 percent of the study’s patients. Non-Profit’s $300 Hepatitis C Cure Rivals Current $48,000-Plus ...
The efficacy and safety for these two novel therapies among various subpopulations of those infected with chronic hepatitis C are discussed in the following review. In addition, off-label and future therapeutic regimens are addressed, as well as the concerns about cost of current and future ...
Young adults respond better with this vaccine. Because of its low cost, the vaccine may be a good choice in prevention of hepatitis B infection. 展开 关键词: Hepatitis B vaccine GeneVac-B Adults Immunogenicity Reactogenicity Cost DOI: 10.1016/j.vaccine.2006.02.008 被引量: 31 年份: 2006 ...
(2020). “The Cost-Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach”, Pharmacoeconomics – Open; DOI: https://doi.org/10.1007/s41669-020-00238-3 Elliot, J. C., Hasin, D. S., & Des Jarlais, D. C. (2017)....
A study led by Boston Medical Center (BMC) researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients. The findings of the study, led by Benjamin P....
A newly published Burnet Institute study has demonstrated the feasibility and effectiveness of simplified clinical pathways for treatment of hepatitis C (HCV) in Myanmar.